Understanding How the Eye Sees Light Without Common Sensors
Transducin and melanopsin independent phototransduction in postnatal retinal development
This project aims to discover a new way our eyes detect light, even when the usual light-sensing cells are not working as expected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11128744 on NIH RePORTER |
What this research studies
Our eyes usually detect light using special cells called rods and cones, which rely on a protein called transducin. However, we've found that some inner eye cells can still respond to light even when transducin isn't working, and this response also doesn't depend on another known light sensor called melanopsin. This unexpected light sensing, which we call TMIP, seems to use a new and unknown process within the eye. We want to find out exactly which cells are responsible for TMIP, what molecules are involved, and how it helps the eye develop normally after birth. Understanding TMIP could reveal new ways our vision system works.
Who could benefit from this research
Good fit: This foundational research does not involve direct patient participation at this stage, but future clinical applications may benefit individuals with retinal conditions.
Not a fit: Patients seeking immediate new treatments for vision loss will not directly benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of how vision develops and functions, potentially opening new avenues for treating certain vision problems.
How similar studies have performed: This project explores a newly discovered and unexpected light-sensing mechanism, making the approach novel and largely untested.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Chen, Ching-Kang Jason — University of Texas Hlth Science Center
- Study coordinator: Chen, Ching-Kang Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.